Wave Life Sciences Ltd. (WVE) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
Wave Life Sciences Ltd. (WVE) Profile & Business Summary
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.
Key Information
| Ticker | WVE |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://www.wavelifesciences.com |
Market Trend Overview for WVE
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-03-25 (ET)
As of 2026-03-25, WVE is showing signs of slowing down. Over the longer term, the trend remains bullish.
WVE last closed at 12.30. The price is about 0.2 ATR below its recent average price (12.70), and the market is currently in a trend that may be losing strength. Price at 12.30 is near minor support around 11.08. Momentum may slow, while minor resistance sits near 14.15. View Support & Resistance from Options
The broader uptrend is still intact, but price has moved far from its recent average, increasing the risk of a pullback.
Trend score: 55 out of 100. Overall alignment is unclear. The market is currently in a late-stage trend that may be losing strength. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside level is near 11.60. If price falls below this area, the current upward trend would likely weaken or break.
On 2026-03-17, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-02-17] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Some late-day positioning was observed, but it lacked strong overnight commitment.
The model stays neutral because the setup is not clear enough to justify a directional deployment.
The model does not deploy this setup because predictability is still too low, price is still close to a gamma transition zone, and recent price behavior has shown failed reversal memory. Predictability is 30%, agreement is 62%, and reversal risk is 30%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is modestly below the recent estimated cost basis of 12.52, so the recent structure is still leaning somewhat under pressure. Price is above the main cost band (11.44 to 12.24), which keeps the recent structure constructive, although extension risk starts to matter more from here. The lower down support area sits around 11.30 to 11.36. The higher up selling area sits around 12.58 to 12.64, so rebounds may begin to slow as price pushes into that zone. Recent positioning looks fairly balanced, with 51% in profit and 49% under water. From a trading point of view, the structure is still best read by comparing price with the main cost band first, then watching whether the lower support zone or higher supply zone becomes the next directional checkpoint.
Short Interest & Covering Risk for WVE
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is within its typical range, with no clear imbalance between buyers and sellers. (Historical percentile: 50%)
Structure Analysis
WVE Short positioning looks normal. Current days to cover is 5.4 trading days, meaning short positions would unwind somewhat slower than average. Short covering is likely to have a normal impact on price moves. Price is already trending lower (20D return -15.4%). The current configuration reflects active downside pressure rather than latent structural fragility.
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
Days-to-Cover is elevated versus its own history, but absolute short interest remains moderate. Average trading volume is weakening, indicating contracting liquidity. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-02-27 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.